Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 10/06/21
End: 12/28/23
Due: 12/28/24
Phase: N/A
Priority: Normal
Start: 06/13/19
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 03/31/21
Due: 03/31/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Polish Microbiome Map | NCT04169867 | Ardigen | user2@example.com | None | 2018-01-01 | 2020-12-31 | 2021-12-31 | - | - | 2025-07-14 |
| Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies | NCT04994093 | Ardigen | user2@example.com | None | 2021-10-06 | 2023-12-28 | 2024-12-28 | - | - | 2025-07-14 |
| AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies. | NCT04145232 | Ardigen | user2@example.com | None | 2019-06-13 | 2020-11-30 | 2021-11-30 | - | - | 2025-07-14 |
| BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics | NCT04136470 | Ardigen | user2@example.com | None | 2019-04-01 | 2021-03-31 | 2022-03-31 | - | - | 2025-07-14 |